HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today announced that it has filed its audited financial statements for the three years ended December 31, 2006, which include restated financial statements for prior years in a Form 6-K with the U.S. Securities and Exchange Commission. The Company said that it will now turn its attention to the financial statements for 2007, 2008 and 2009.
